Physiologic Effect · N0000008347
Cellular Synthetic Activity Alteration
Pharmacological class containing 15 drugs per the Physiologic Effect taxonomy.
Drugs in this class (15)
Need clinical context — common uses, side effects, or interactions for this class?
Ask GoDavaii AI about Cellular Synthetic Activity AlterationCommon questions about Cellular Synthetic Activity Alteration
What is the Cellular Synthetic Activity Alteration drug class?
Cellular Synthetic Activity Alteration is a pharmacological class in the Physiologic Effect taxonomy, classification code N0000008347. It groups 15 drugs that share a similar mechanism of action, chemical structure, or therapeutic use.
Which drugs are part of the Cellular Synthetic Activity Alteration class?
Notable drugs in the Cellular Synthetic Activity Alteration class include mipomersen, azelaic acid, nusinersen, inotuzumab ozogamicin, patisiran, and 10 more. The complete member list is shown above on this page; tap any drug name to see its full Indian-context information sheet.
What does Physiologic Effect mean?
Physiologic Effect is one of the standard taxonomies used by the NIH National Library of Medicine to organise drugs. Different taxonomies group drugs by different criteria - some by chemical structure, some by what they do in the body, some by therapeutic intent. Together these classifications make medical research, prescribing and education more consistent across the world.
Where can I get plain-language clinical context for the Cellular Synthetic Activity Alteration class?
For plain-language clinical context - common uses, side effects, drug interactions and what the class means for an Indian patient - ask GoDavaii's Health AI. It works in 22+ Indian languages, is free and needs no signup. Tap "Ask GoDavaii AI about Cellular Synthetic Activity Alteration" above.
Source: NIH RxClass — National Library of Medicine, public domain. Class taxonomy: Physiologic Effect. View on RxClass ↗